Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 26, 2022

SELL
$58.92 - $84.67 $841,377 - $1.21 Million
-14,280 Reduced 16.5%
72,290 $4.47 Million
Q2 2022

Jul 18, 2022

BUY
$79.4 - $116.36 $3.1 Million - $4.55 Million
39,100 Added 82.37%
86,570 $6.91 Million
Q1 2022

Apr 11, 2022

SELL
$86.42 - $109.81 $1.63 Million - $2.07 Million
-18,840 Reduced 28.41%
47,470 $4.99 Million
Q4 2021

Jan 25, 2022

SELL
$98.56 - $119.91 $43,366 - $52,760
-440 Reduced 0.66%
66,310 $7.15 Million
Q3 2021

Oct 13, 2021

SELL
$91.91 - $110.37 $7.16 Million - $8.59 Million
-77,850 Reduced 53.84%
66,750 $7.31 Million
Q1 2021

Apr 21, 2021

SELL
$71.83 - $95.48 $215,490 - $286,440
-3,000 Reduced 2.03%
144,600 $13.3 Million
Q4 2020

Jan 20, 2021

BUY
$67.0 - $84.39 $3.36 Million - $4.23 Million
50,100 Added 51.38%
147,600 $10.8 Million
Q3 2020

Oct 23, 2020

BUY
$55.23 - $79.93 $5.38 Million - $7.79 Million
97,500 New
97,500 $7.57 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Deltec Asset Management LLC Portfolio

Follow Deltec Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deltec Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Deltec Asset Management LLC with notifications on news.